Bispecific antibodies can simultaneously address two different antigens, which are sufficient to target two trails involved in cancer pathogenesis, and therefore, provide advantages over monoclonal antibodies therapy.

Scope of the Report:

The worldwide market for Bispecific Antibodies for Cancer is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019.

This report focuses on the Bispecific Antibodies for Cancer in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

Amgen

Astella Pharma

Ben Kang Biopharmaceutical (Shenzhen)

Merus

Regeneron Pharmaceuticals

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

CD19/CD3

CD30/CD16A

Market Segment by Applications, can be divided into

Hospital

Pharmaceutical Companies

Other

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Bispecific Antibodies for Cancer product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Bispecific Antibodies for Cancer, with price, sales, revenue and global market share of Bispecific Antibodies for Cancer in 2017 and 2018.

Chapter 3, the Bispecific Antibodies for Cancer competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Bispecific Antibodies for Cancer breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.

Chapter 12, Bispecific Antibodies for Cancer market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.

Chapter 13, 14 and 15, to describe Bispecific Antibodies for Cancer sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview

1.1 Bispecific Antibodies for Cancer Introduction

1.2 Market Analysis by Type

1.2.1 CD19/CD3

1.2.2 CD30/CD16A

1.3 Market Analysis by Applications

1.3.1 Hospital

1.3.2 Pharmaceutical Companies

1.3.3 Other

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2014-2024)

1.4.1.2 Canada Market States and Outlook (2014-2024)

1.4.1.3 Mexico Market States and Outlook (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2014-2024)

1.4.2.2 France Market States and Outlook (2014-2024)

1.4.2.3 UK Market States and Outlook (2014-2024)

1.4.2.4 Russia Market States and Outlook (2014-2024)

1.4.2.5 Italy Market States and Outlook (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2014-2024)

1.4.3.2 Japan Market States and Outlook (2014-2024)

1.4.3.3 Korea Market States and Outlook (2014-2024)

1.4.3.4 India Market States and Outlook (2014-2024)

1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2014-2024)

1.4.4.2 Egypt Market States and Outlook (2014-2024)

1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)

1.4.4.4 South Africa Market States and Outlook (2014-2024)

1.4.4.5 Turkey Market States and Outlook (2014-2024)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Amgen

2.1.1 Business Overview

2.1.2 Bispecific Antibodies for Cancer Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Amgen Bispecific Antibodies for Cancer Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.2 Astella Pharma

2.2.1 Business Overview

2.2.2 Bispecific Antibodies for Cancer Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Astella Pharma Bispecific Antibodies for Cancer Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.3 Ben Kang Biopharmaceutical (Shenzhen)

2.3.1 Business Overview

2.3.2 Bispecific Antibodies for Cancer Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Ben Kang Biopharmaceutical (Shenzhen) Bispecific Antibodies for Cancer Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.4 Merus

2.4.1 Business Overview

2.4.2 Bispecific Antibodies for Cancer Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Merus Bispecific Antibodies for Cancer Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.5 Regeneron Pharmaceuticals

2.5.1 Business Overview

2.5.2 Bispecific Antibodies for Cancer Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Regeneron Pharmaceuticals Bispecific Antibodies for Cancer Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

3 Global Bispecific Antibodies for Cancer Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

3.1 Global Bispecific Antibodies for Cancer Sales and Market Share by Manufacturer (2017-2018)

3.2 Global Bispecific Antibodies for Cancer Revenue and Market Share by Manufacturer (2017-2018)

3.3 Market Concentration Rate

3.3.1 Top 3 Bispecific Antibodies for Cancer Manufacturer Market Share in 2018

3.3.2 Top 6 Bispecific Antibodies for Cancer Manufacturer Market Share in 2018

3.4 Market Competition Trend

4 Global Bispecific Antibodies for Cancer Market Analysis by Regions

4.1 Global Bispecific Antibodies for Cancer Sales, Revenue and Market Share by Regions

4.1.1 Global Bispecific Antibodies for Cancer Sales and Market Share by Regions (2014-2019)

4.1.2 Global Bispecific Antibodies for Cancer Revenue and Market Share by Regions (2014-2019)

4.2 North America Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)

4.3 Europe Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)

4.4 Asia-Pacific Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)

4.5 South America Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)

4.6 Middle East and Africa Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)

5 North America Bispecific Antibodies for Cancer by Country

5.1 North America Bispecific Antibodies for Cancer Sales, Revenue and Market Share by Country

5.1.1 North America Bispecific Antibodies for Cancer Sales and Market Share by Country (2014-2019)

5.1.2 North America Bispecific Antibodies for Cancer Revenue and Market Share by Country (2014-2019)

5.2 United States Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)

5.3 Canada Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)

5.4 Mexico Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)

6 Europe Bispecific Antibodies for Cancer by Country

6.1 Europe Bispecific Antibodies for Cancer Sales, Revenue and Market Share by Country

6.1.1 Europe Bispecific Antibodies for Cancer Sales and Market Share by Country (2014-2019)

6.1.2 Europe Bispecific Antibodies for Cancer Revenue and Market Share by Country (2014-2019)

6.2 Germany Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)

6.3 UK Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)

6.4 France Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)

6.5 Russia Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)

6.6 Italy Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)

7 Asia-Pacific Bispecific Antibodies for Cancer by Country

7.1 Asia-Pacific Bispecific Antibodies for Cancer Sales, Revenue and Market Share by Country

7.1.1 Asia-Pacific Bispecific Antibodies for Cancer Sales and Market Share by Country (2014-2019)

7.1.2 Asia-Pacific Bispecific Antibodies for Cancer Revenue and Market Share by Country (2014-2019)

7.2 China Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)

7.3 Japan Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)

7.4 Korea Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)

7.5 India Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)

7.6 Southeast Asia Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)

8 South America Bispecific Antibodies for Cancer by Country

8.1 South America Bispecific Antibodies for Cancer Sales, Revenue and Market Share by Country

8.1.1 South America Bispecific Antibodies for Cancer Sales and Market Share by Country (2014-2019)

8.1.2 South America Bispecific Antibodies for Cancer Revenue and Market Share by Country (2014-2019)

8.2 Brazil Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)

8.3 Argentina Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)

8.4 Colombia Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)

9 Middle East and Africa Bispecific Antibodies for Cancer by Countries

9.1 Middle East and Africa Bispecific Antibodies for Cancer Sales, Revenue and Market Share by Country

9.1.1 Middle East and Africa Bispecific Antibodies for Cancer Sales and Market Share by Country (2014-2019)

9.1.2 Middle East and Africa Bispecific Antibodies for Cancer Revenue and Market Share by Country (2014-2019)

9.2 Saudi Arabia Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)

9.3 Turkey Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)

9.4 Egypt Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)

9.5 Nigeria Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)

9.6 South Africa Bispecific Antibodies for Cancer Sales and Growth Rate (2014-2019)

10 Global Bispecific Antibodies for Cancer Market Segment by Type

10.1 Global Bispecific Antibodies for Cancer Sales, Revenue and Market Share by Type (2014-2019)

10.1.1 Global Bispecific Antibodies for Cancer Sales and Market Share by Type (2014-2019)

10.1.2 Global Bispecific Antibodies for Cancer Revenue and Market Share by Type (2014-2019)

10.2 CD19/CD3 Sales Growth and Price

10.2.1 Global CD19/CD3 Sales Growth (2014-2019)

10.2.2 Global CD19/CD3 Price (2014-2019)

10.3 CD30/CD16A Sales Growth and Price

10.3.1 Global CD30/CD16A Sales Growth (2014-2019)

10.3.2 Global CD30/CD16A Price (2014-2019)

11 Global Bispecific Antibodies for Cancer Market Segment by Application

11.1 Global Bispecific Antibodies for Cancer Sales Market Share by Application (2014-2019)

11.2 Hospital Sales Growth (2014-2019)

11.3 Pharmaceutical Companies Sales Growth (2014-2019)

11.4 Other Sales Growth (2014-2019)

12 Bispecific Antibodies for Cancer Market Forecast (2019-2024)

12.1 Global Bispecific Antibodies for Cancer Sales, Revenue and Growth Rate (2019-2024)

12.2 Bispecific Antibodies for Cancer Market Forecast by Regions (2019-2024)

12.2.1 North America Bispecific Antibodies for Cancer Market Forecast (2019-2024)

12.2.2 Europe Bispecific Antibodies for Cancer Market Forecast (2019-2024)

12.2.3 Asia-Pacific Bispecific Antibodies for Cancer Market Forecast (2019-2024)

12.2.4 South America Bispecific Antibodies for Cancer Market Forecast (2019-2024)

12.2.5 Middle East and Africa Bispecific Antibodies for Cancer Market Forecast (2019-2024)

12.3 Bispecific Antibodies for Cancer Market Forecast by Type (2019-2024)

12.3.1 Global Bispecific Antibodies for Cancer Sales Forecast by Type (2019-2024)

12.3.2 Global Bispecific Antibodies for Cancer Market Share Forecast by Type (2019-2024)

12.4 Bispecific Antibodies for Cancer Market Forecast by Application (2019-2024)

12.4.1 Global Bispecific Antibodies for Cancer Sales Forecast by Application (2019-2024)

12.4.2 Global Bispecific Antibodies for Cancer Market Share Forecast by Application (2019-2024)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Bispecific Antibodies for Cancer Picture

Table Product Specifications of Bispecific Antibodies for Cancer

Figure Global Sales Market Share of Bispecific Antibodies f